YOLFTbeta
TherapeuticsMD Inc

TherapeuticsMD Inc

TXMD · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

1.87USD+0.05 (+2.75%)

Price History

Full chart

Market Stats

Previous Close1.82
Open1.79
Day Range1.74 – 1.89
52-Week Range0.99 – 2.95
Volume50.50K
Market Cap23.73M
P/E (TTM)0.00
Forward P/E2.33
EPS-0.03
Dividend Yield0.00%
Beta0.65
50-Day Avg2.11
200-Day Avg2.10

About

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Marlan D. Walker J.D.
  • Employees1
  • Headquarters951 Yamato Road, Boca Raton, FL, United States, 33431, USA
  • Websitehttps://www.therapeuticsmd.com

Leadership

  • Mr. Marlan D. Walker J.D.Chief Executive Officer · b. 1976
  • Mr. Joseph A. ZieglerPrincipal Financial & Accounting Officer · b. 1974

Financials

Income Statement

Currency: USD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue201.18K196.78K195.83K216.87K193.10K193.97K214.19K368.02K332.57K286.60K437.59K621.93K968.09K1.01M--10.57K1.24M2.09M3.82M8.78M15.03M20.14M19.36M16.78M16.10M49.65M64.87M2.57M69.96M1.30M1.76M3.02M
Growth (%)--2.19%-0.48%+10.74%-10.96%+0.45%+10.42%+71.82%-9.63%-13.82%+52.68%+42.13%+55.66%+3.84%---+11650.60%+68.14%+82.84%+129.85%+71.23%+34.05%-3.90%-13.32%-4.04%+208.38%+30.67%-96.03%+2619.12%-98.14%+35.25%+71.61%
Cost of Revenue59.35K51.98K55.58K58.36K40.82K68.98K66.53K87.92K116.19K77.06K130.79K192.19K272.13K205.37K--43.15K556.39K947.11K1.35M1.96M3.67M4.51M4.19M2.64M2.74M6.33M15.97M1.40M1.40M922.00K509.00K1.19M
Gross Profit141.84K144.80K140.25K158.51K152.28K124.99K147.66K280.10K216.38K209.54K306.79K429.74K695.96K799.90K--10.57K685.53K1.14M2.47M6.82M11.35M15.64M15.17M14.14M13.36M43.31M48.90M1.17M68.57M1.30M1.76M3.02M
Gross Margin70.50%73.58%71.62%73.09%78.86%64.44%68.94%76.11%65.06%73.11%70.11%69.10%71.89%79.57%--100.00%55.20%54.64%64.69%77.67%75.56%77.63%78.38%84.28%83.00%87.24%75.37%45.51%98.00%100.00%100.00%100.00%
Operating Expense99.26K110.61K104.15K84.05K103.01K129.83K134.83K148.43K154.85K110.63K202.68K232.98K313.40K935.09K--1.66M3.55M6.57M18.62M32.62M65.40M100.83M105.42M91.77M143.58M194.52M204.44M80.75M57.90M9.82M6.61M7.24M
Operating Income42.58K34.18K36.10K74.46K49.26K-4.84K12.82K131.67K61.53K98.91K104.11K196.76K382.55K-135.19K-93.74K-395.55K-1.65M-2.87M-5.43M-16.15M-25.81M-54.04M-85.19M-90.25M-77.63M-130.22M-151.21M-155.54M-79.58M10.66M-8.52M-4.84M-4.21M
Operating Margin21.16%17.37%18.44%34.34%25.51%-2.49%5.99%35.78%18.50%34.51%23.79%31.64%39.52%-13.45%---15570.87%-230.89%-259.90%-422.95%-294.09%-359.65%-422.93%-466.27%-462.69%-808.85%-304.56%-239.77%-3092.77%15.24%-654.61%-275.07%-139.44%
EBITDA63.65K66.67K66.35K95.22K8.37K29.74K61.49K200.33K137.45K131.89K208.46K238.76K437.74K-80.82K-93.74K-395.55K-1.57M-2.84M-12.79M-33.16M-25.69M-53.90M-85.13M-89.74M-76.71M-127.65M-158.23M-153.41M-78.84M11.86M-7.60M-3.56M-3.02M
EBITDA Margin31.64%33.88%33.88%43.91%4.33%15.33%28.71%54.43%41.33%46.02%47.64%38.39%45.22%-8.04%---14849.86%-229.05%-612.69%-868.48%-292.76%-358.74%-422.62%-463.63%-457.23%-792.86%-318.70%-236.48%-3064.17%16.96%-583.79%-202.39%-99.97%
Net Income42.58K34.18K31.51K73.79K-12.74K-15.58K12.43K31.67K61.53K98.91K94.11K142.12K323.45K136.03K170.54K-395.55K-1.65M-2.87M-12.91M-35.12M-28.42M-54.22M-85.08M-89.88M-76.93M-132.62M-176.15M-183.52M-172.41M112.00M-10.28M-2.18M-569.00K
Net Income Margin21.16%17.37%16.09%34.03%-6.60%-8.03%5.80%8.60%18.50%34.51%21.51%22.85%33.41%13.53%---15654.66%-230.89%-618.40%-919.86%-323.84%-360.82%-422.37%-464.32%-458.50%-823.74%-354.79%-282.90%-6700.93%160.08%-789.40%-123.85%-18.83%
R&D------------------107.24K4.49M13.55M43.22M72.04M53.94M33.85M27.30M19.79M10.43M7.09M5.51M---
R&D as % of Total Revenue------------------5.14%117.66%154.42%287.62%357.66%278.68%201.77%169.57%39.87%16.08%275.40%7.88%---
Interest Expense004.59K67005.75K3950000000008.86K64.09K64.38K1.91M2.67M260.03K0004.68M17.38M28.58M32.92M12.27M200.00K9.50K8.00K
Interest Expense % of Total Revenue0.00%0.00%2.34%0.31%0.00%2.96%0.18%0.00%0.00%0.00%0.00%0.00%0.00%0.00%--83.79%5.16%3.08%49.91%30.42%1.73%0.00%0.00%0.00%29.06%35.01%44.06%1279.32%17.54%15.36%0.54%0.26%

Balance Sheet

Currency: USD1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets---430.33K505.02K515.70K504.88K508.85K498.16K628.17K695.12K753.21K898.22K1.09M1.81M1.87M495.36K54.42K849.76K467.42K1.44M5.82M62.02M59.08M73.73M142.47M143.23M211.98M265.99M181.61M169.47M90.46M43.31M38.82M37.66M
Total Liabilities---11.47K64.49K4.82K6.98K50.72K17.81K16.21K23.04K16.80K32.11K37.12K493.18K179.83K77.83K35.72K1.16M1.37M3.15M7.25M7.32M10.69M10.67M14.98M13.32M114.46M256.78M305.61M263.09M55.31M14.02M11.45M10.78M
Total Equity---418.86K440.53K510.88K497.89K458.12K480.35K611.97K672.09K736.41K866.11K1.05M1.31M1.69M417.54K18.70K-311.05K-907.55K-1.71M-1.43M54.70M48.39M63.06M127.49M129.91M97.52M9.20M-124.00M-93.62M35.14M29.29M27.37M26.88M
Cash---19.39K37.93K-166.88K14.29K57.72K191.63K338.87K316.47K154.49K257.67K902.26K985.73K408.63K54.42K42.07K1.50K126.42K1.55M54.19M51.36M64.71M131.53M127.14M161.61M160.83M80.49M64.91M38.07M4.33M5.06M7.48M
Total Debt----50.00K--23.37K------81.83K---600.00K753.53K2.15M3.59M-----73.38M205.28M248.63M197.69M8.76M8.01M7.17M6.10M
Net Debt----19.39K12.07K--166.88K9.07K-57.72K-191.63K-338.87K-316.47K-154.49K-257.67K-820.43K-985.73K-408.63K-54.42K557.93K752.03K2.02M2.04M-54.19M-51.36M-64.71M-131.53M-127.14M-88.23M44.45M168.14M132.79M-29.31M3.68M2.12M-1.39M

Cash Flow

Currency: USD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow59.76K72.86K63.45K58.78K77.53K44.60K48.53K133.97K161.95K100.08K140.00K207.73K412.34K329.84K344.10K-133.00K-417.34K836.83K-4.97M-12.74M-20.77M-45.52M-79.04M-69.14M-76.16M-106.81M-165.70M-159.47M-147.81M-4.08M-48.14M732.00K2.42M
Investing Cash Flow-46.44K-74.35K-85.06K141.29K-94.96K-196.37K8.46K--14.51K-152.47K-311.99K-104.55K-68.37K54.25K22.76K--841.30K-285.50K-37.64K-272.51K-583.56K-606.76K-584.36K-1.26M-827.11K-21.50M-23.91M-1.60M-2.22M223.48M---
Financing Cash Flow-105-40.16K-53.44K-250-818-13.57K-55-20030.00K10.00K-300.62K-300.62K-943.95K-221.21K1.30M-550.00K4.71M14.44M73.99M43.30M92.97M137.23M72.58M162.79M188.83M80.72M134.67M-235.21M3.15M0-
Capital Expenditure90.00K70.35K10.56K095.40K211.37K0021.70K62.66K247.71K311.05K92.23K57.75K00841.30K037.64K272.51K479.82K617.44K584.36K1.24M827.11K21.32M23.89M1.60M34.00K355.00K48.14M00
Free Cash Flow-30.24K2.50K52.89K58.78K-17.88K-166.77K48.53K133.97K140.24K37.41K-107.70K-103.33K320.11K272.09K344.10K-133.00K-1.26M836.83K-5.00M-13.01M-21.25M-46.14M-79.63M-70.38M-76.98M-128.13M-189.59M-161.07M-147.84M-4.43M-48.14M732.00K2.42M
Dividends Paid---------------174.64K--0000000--------
FCF to OCF-50.59%3.44%83.36%100.00%-23.06%-373.94%100.00%100.00%86.60%37.38%-76.93%-49.74%77.63%82.49%100.00%100.00%301.59%100.00%100.76%102.14%102.31%101.36%100.74%101.80%101.09%119.96%114.42%101.00%100.02%108.71%100.00%100.00%100.00%
Dividend Paid to FCF----------------131.31%--0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateMar 31, 2002Dec 31, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Nov 28, 2012Feb 27, 2013May 8, 2013Aug 6, 2013Nov 4, 2013Mar 3, 2014May 5, 2014Aug 6, 2014Nov 6, 2014Mar 10, 2015May 5, 2015Aug 6, 2015Nov 4, 2015Feb 25, 2016May 3, 2016Aug 4, 2016Nov 3, 2016Feb 23, 2017May 2, 2017Aug 3, 2017Nov 6, 2017Feb 20, 2018May 3, 2018Jul 30, 2018Nov 7, 2018Feb 21, 2019May 6, 2019Aug 6, 2019Nov 6, 2019Feb 20, 2020May 6, 2020Aug 6, 2020Nov 9, 2020Mar 2, 2021May 6, 2021Aug 4, 2021Nov 11, 2021Mar 10, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 27, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Mar 29, 2024May 10, 2024Aug 12, 2024Nov 12, 2024Mar 27, 2025May 8, 2025Aug 12, 2025Nov 12, 2025Mar 27, 2026May 18, 2026Aug 11, 2026Nov 11, 2026
EPS Estimate-------------------------------------------2.50-3.00-2.25-2.75-2.83-3.75-3.75-4.50-5.00-5.62-6.12-5.00-4.50-5.20-6.00-6.21-5.58-5.43-5.39-4.25-4.95-6.17-9.58-8.50-8.49-8.81-9.50-9.36-9.30-8.17-6.70-5.25-5.80-5.50-5.00-3.83-4.00-3.04-2.04-1.110.06-0.07-0.05-0.130.030.030.040.04-0.000.000.000.00--
EPS Actual69.121.061.991.0116.98-3.12-129.77-4.16-47.80-28.4539.92-144.5947.62-20.537.254.94238.23-5.9410.529.019.18117.11-98.81-738.98-69.16-23.15-43.69-23.21-210.74-434.51-110.00-84.659.19-33.14185.05-17.22-23.69-10.15-7.86-6.88-2.22-2.87-3.00-2.50-3.00-3.00-3.00-3.50-6.00-5.00-6.50-8.00-5.50-5.00-5.50-5.50-6.50-6.00-5.50-5.00-3.50-5.00-5.50-7.50-8.00-8.50-8.00-9.50-6.50-9.50-10.50-9.50-6.00-7.50-5.50-5.50-5.50-5.00-5.6912.39-3.138.23-0.24-0.24-0.32-0.08-0.08-0.09-0.050.020.020.050.000.000.000.01-
Surprise-------------------------------------------20.00%16.67%-33.33%-9.09%-6.01%6.67%-60.00%-11.11%-30.00%-42.35%10.13%0.00%-22.22%-5.77%-8.33%3.38%1.43%7.92%35.06%-17.65%-11.11%-21.56%16.49%0.00%5.77%-7.83%31.58%-1.50%-12.90%-16.28%10.45%-42.86%5.17%0.00%-10.00%-30.55%-42.25%507.57%-53.43%841.44%-500.00%-242.86%-540.00%38.46%-355.33%-415.00%-232.00%-45.25%-------
Timing------------------------------------------After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market------

Key Statistics & Ratios

Market Cap23.73M
Enterprise Value21.37M
Trailing P/E0.00
Forward P/E2.33
PEG Ratio-0.73
Price / Sales7.26
Price / Book0.92
EPS-0.03
Book Value2.33
Revenue (TTM)3.27M
Gross Profit (TTM)3.27M
EBITDA-1.37M
Profit Margin-6.64%
Operating Margin-32.22%
Return on Equity-1.08%
Return on Assets-2.88%
Shares Outstanding11.57M
Shares Float9.49M
Beta0.65
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 1 analystsTarget 5.00
  • Hold
    1

Ownership Breakdown

Institutions
31.73%
Insiders
9.04%
Retail / Other
59.23%

Top Institutional Holders

  • Rubric Capital Management LP
    1.19M10.30%
  • Clearline Capital LP
    635.22K5.49%
  • Vanguard Capital Management, LLC
    353.70K3.06%
  • Tejara Capital Ltd
    344.48K2.98%
  • ADAR1 Capital Management LLC
    209.21K1.81%
  • Renaissance Technologies Corp
    146.20K1.26%
  • Morgan Stanley - Brokerage Accounts
    129.22K1.12%
  • BlackRock Inc
    115.14K0.99%
  • Geode Capital Management, LLC
    109.82K0.95%
  • Citadel Advisors Llc
    86.09K0.74%
  • Vanguard Fiduciary Trust Co
    63.83K0.55%
  • State Street Corp
    30.10K0.26%
  • XTX Topco Ltd
    27.49K0.24%
  • Susquehanna International Group, LLP
    21.22K0.18%
  • Dimensional Fund Advisors, Inc.
    19.72K0.17%
  • Bridgeway Capital Management, LLC
    17.00K0.15%
  • Northern Trust Corp
    16.09K0.14%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    244.32K2.11%
  • Fidelity Extended Market Index
    61.01K0.53%
  • EA Bridgeway Ultra-Small Company Mkt ETF
    16.88K0.15%

Dividends

20081×
13.33Jun 6, 2008

Stock Splits

  • May 9, 20221:50
  • Oct 3, 20111:100
  • Jul 27, 20093:1